NovaBay Pharmaceuticals I... (NBY)
AMEX: NBY
· Real-Time Price · USD
4.19
1.51 (56.34%)
At close: Sep 04, 2025, 3:59 PM
3.94
-5.97%
Pre-market: Sep 05, 2025, 09:18 AM EDT
56.34% (1D)
| Bid | 4.14 |
| Market Cap | 24.39M |
| Revenue (ttm) | 4.75M |
| Net Income (ttm) | 3.32M |
| EPS (ttm) | 2.3 |
| PE Ratio (ttm) | 1.82 |
| Forward PE | -7.04 |
| Analyst | Buy |
| Ask | 4.17 |
| Volume | 18,335,179 |
| Avg. Volume (20D) | 6,250,754 |
| Open | 2.77 |
| Previous Close | 2.68 |
| Day's Range | 2.77 - 4.44 |
| 52-Week Range | 0.44 - 4.44 |
| Beta | 0.63 |
Analyst Forecast
According to 0 analyst ratings, the average rating for NBY stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 week ago
+72.42%
NovaBay Pharmaceuticals shares are trading higher ...
Unlock content with
Pro Subscription
1 week ago
-0.83%
NovaBay Pharmaceuticals shares are trading higher after the company announced a one-time special cash dividend of $0.80 per share.
